enVVeno Medical Corporation (NVNOW) Financial Analysis & Valuation | Quarter Chart
enVVeno Medical Corporation (NVNOW)
NVNOWPrice: $0.01
Fair Value: 🔒
🔒score
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatmen... more
enVVeno Medical Corporation, a medical device company, focuses on the development of various biopros... more
Description
Shares
| Market Cap | $73.65M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Robert A. Berman |
| IPO Date | 2018-06-14 | CAGR | — |
| Employees | 30 | Website | www.envveno.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
NVNOW chart loading...
Fundamentals
Technicals
| Enterprise Value | $17.51M | P/E Ratio | -0 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 16.14 | P/B Ratio | 0.44 |
| P/CF Ratio | -0.76 | P/FCF Ratio | -0.76 |
| EPS | $-1.9 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | — | Gross Margin | 0.04% |
| Operating Margin | -29.05% | Profit Margin | -27.05% |
| ROE | -0.61% | ROA | -0.68% |
| ROCE | -0.79% | Current Ratio | 13.12 |
| Quick Ratio | 13.12 | Cash Ratio | 0.64 |
| Debt/Equity | 0.03 | Interest Coverage | — |
| Altman Z Score | 6.62 | Piotroski Score | 1 |